Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Two Methods of Combined Less Dense Laser and Bevacizumab Treatment of Pre-threshold ROP Type 1 Zone 2 (Stair Method)
IRCT20201120049450N5Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab in retinopathy of prematurity (ROP), sponsored by Shiraz University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
bevacizumab
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on IRCT20201120049450N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201120049450N5.